Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stem cells can be transplanted to the retina

18.03.2004


Transplanting stem cells to a diseased retina may be a method of treating certain common eye disorders in the future. In her dissertation, Lund scientist Anita Blixt Wojciechowski reports research findings that enhance the knowledge needed to make this treatment possible.



Retinitis pigmentosa is a hereditary retinal disease that affects one person in 3,500 and leads to severe vision impairment or blindness. Age-related deterioration of the yellow spot, the part of the retina that is most crucial to sharp vision, is another common cause of vision impairment. This disease (age related macular disease) affects nearly a third of all people over the age of 75. Today there is no good treatment for either disease.

Anita Blixt Wojciechowski’s research involves transplanting fetal stem cells from rats to the eyes of adult rats. She has experienced both success and failure in her work.


- We managed to get the transplanted cells to integrate and spread in the host’s retina. On the other hand, they did not develop into new, healthy nerve cells but rather into glia cells, which constitute a sort of support tissue, she says.

Many research teams have had trouble getting stem cells to develop into nerve cells. But there is an alternative solution. It should be possible to have the transplanted cells carry with them growth factors and other substances that can save the sick cells. They could also be supplied with genes that produce the substances that the sick cells are no longer capable of producing. For these purposes the transplanted stem cells do not need to develop into nerve cells. They can just as well be glia cells.

The ideal solution in the future would be to take stem cells from the patients themselves, according to Anita Blixt Wojciechowski. There are in fact stem cells on the edge of the retina even in adults. If these could be removed, cultivated in larger quantities, supplied with genes to produce the necessary substances, and then transplanted back into the diseased eye, there would be no problems of rejection and no ethical problems involving fetal stem cells. It’s a long road, but a few steps have now been taken in the right direction.

Ingela Björck | alfa
Further information:
http://www.lub.lu.se/cgi-bin/show_diss.pl?db=global&fname=med_902.html

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>